job ratings (see below graph) for Big Pharma

11/28/24
industry:
Big Pharma
company:
job rating:
1 - I hate my job
Unfortunately J&J is also actively supporting H1B visas initiative. This makes more difficult for American citizens to get meaningful and reasonably paid jobs here. Government statistics say that about 70% H1B visa recipients are Indian nationals.
11/22/24
industry:
Big Pharma
company:
job rating:
1 - I hate my job
Microsoft should be proud. Produced the Excel tool, which heavenly justice unleashed upon the Amgen crooks.
08/22/24
industry:
Big Pharma
company:
job rating:
2
A confused company. Between DEI and business "models"
08/06/24
industry:
Big Pharma
company:
job rating:
1 - I hate my job
Genentech lost its edge. Roche never had any edge. They will lose on the deal with Sangamo.
08/02/24
industry:
Big Pharma
company:
job rating:
1 - I hate my job
Thousand Oaks is too close to LA. So it is the LA culture. LA is NJ of the West
07/30/24
industry:
Big Pharma
company:
job rating:
1 - I hate my job
Amgen is ran by a bunch of blowhards that need to hear the loudest voice rather than anything of merit. Anthony in leadership of CDNA has created an environment of that if you dont suck up, youll be ostracized and want to quit.
06/29/24
industry:
Big Pharma
job title:
Sales
company:
job rating:
7 - I love my job
Mgrs. are nice. They are realistic about calls and quotas. Been here 22 years and loveit.
05/12/24
industry:
Big Pharma
company:
job rating:
1 - I hate my job
The extended woke company
02/24/24
industry:
Big Pharma
job title:
Cell Therapy
job rating:
2
It's not the job but management and leadership team's lack of integrity and open racism at senior manager & above level. Growth and development opportunities exist only for white. Promotion prospects directly correlated with incompetence!
01/31/24
industry:
Big Pharma
company:
job rating:
2
Analogy: Like in Kite Biomarin called Roche to send the cavalry to rescue the company. As in Kite it is being done by headcount reduction. Jeff A is a prominent example. Some executive and senior vice-presidents would go soon since they do not contribute but interfere by looking busy. Stock market is not impressed. Rarely companies ask the capable people who already left to return and help rebuild. Rather we may expect people streaming from Genentech and Roche following the CEO. However, they do not have right experience to match the Biomarin niche. Contraction expected, possibly 15% reduction in workforce

Pages

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.